Lucinda Lillford

Ms. Lillford has 23 years' experience working in Regulatory Genetic Toxicology for a global contract research organisation. During this time, she acquired considerable technical knowledge of in-vitro and in-vivo Genetic Toxicology assays and gained several years' experience as a Study Director, focusing on the Ames, in-vivo Micronucleus, in-vivo Comet and MutaTMMouse assays for a variety of indications including Pharmaceuticals, Agrochemicals and Industrial Chemicals. She was also involved in the Japanese Center for the validation of alternative methods (JaCVAM) organized international comet assay validation exercise.

More recently Ms. Lillford focused on managing a team of scientists developing screening tools to allow early identification of potential genotoxicity and using these assays for high throughput screening in Lead Optimisation. This involved using miniaturised versions of the Ames and in-vitro micronucleus assays and other screening tools in order to predict the outcome of regulatory assays.

Ms. Lillford also has experience of six sigma lean process improvement.

Ms. Lillford works across the Chemical Regulation & Food Safety and Health Sciences practices in the Toxicology group and is a member of the UK Mutagenicity Society.